For the year ending 2025-12-31, IEX had -$53,000K decrease in cash & cash equivalents over the period. $616,800K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 482,500 | 504,600 | 595,600 | 586,700 |
| Gains on sales of assets | - | - | - | 3,500 |
| Gain on sale of businesses net | 0 | 4,000 | 84,700 | 34,800 |
| Asset impairments | 700 | 100 | 800 | 17,400 |
| Credit loss on note receivable from collaborative partner | 0 | 0 | 7,700 | - |
| Depreciation | 75,800 | 68,500 | 57,200 | 50,700 |
| Amortization of intangible assets | 130,700 | 107,100 | 94,900 | 69,000 |
| Amortization of debt issuance expenses | - | - | - | 1,700 |
| Share-based compensation expense | 27,300 | 25,800 | 21,800 | 21,600 |
| Deferred income taxes | 12,800 | -19,400 | -14,700 | -18,500 |
| Non-cash interest expense associated with forward starting swaps | - | - | 0 | 0 |
| Termination of the u.s. pension plan, net of curtailment | - | - | 0 | 0 |
| Receivables net | 41,200 | 16,900 | -20,500 | 71,700 |
| Inventories net | 34,200 | -17,600 | -66,200 | 72,400 |
| Other current assets | -1,600 | 100 | 6,500 | 500 |
| Trade accounts payable | 15,200 | 8,900 | -25,300 | 17,600 |
| Deferred revenue | 2,700 | -17,900 | 12,700 | -25,000 |
| Accrued expenses | 1,800 | -8,600 | -34,800 | 16,600 |
| Other net | -4,700 | -2,400 | -5,300 | -2,500 |
| Net cash flows provided by operating activities | 680,400 | 668,100 | 716,700 | 557,400 |
| Capital expenditures | 63,600 | 65,100 | 89,900 | 68,000 |
| Acquisition of businesses, net of cash acquired | 76,200 | 984,500 | 311,800 | 945,600 |
| Note receivable from collaborative partner | - | - | - | 3,000 |
| Proceeds from disposal of fixed assets | - | - | - | 8,900 |
| Proceeds from sale of businesses, net of cash remitted | 0 | 45,100 | 118,600 | 49,400 |
| Purchase of marketable securities | 0 | 0 | 29,000 | 0 |
| Proceeds from sale of marketable securities | 0 | 4,500 | 24,800 | 39,700 |
| Other net | -2,200 | 6,500 | -3,500 | -1,400 |
| Net cash flows used in investing activities | -137,600 | -1,006,500 | -283,800 | -917,200 |
| Borrowings under revolving credit facilities | 252,000 | 279,300 | 0 | 210,400 |
| Payments under revolving credit facilities | 322,900 | 69,100 | 0 | 135,000 |
| Proceeds from issuance of long-term borrowings | 0 | 496,700 | 100,000 | 200,000 |
| Payment of long-term borrowings | 100,000 | 50,000 | 250,000 | 0 |
| Payment of make-whole redemption premium | - | - | 0 | 0 |
| Debt issuance costs | - | 1,700 | - | 2,300 |
| Cash dividends paid to shareholders | 212,600 | 205,300 | 190,700 | 177,400 |
| Proceeds from stock option exercises | - | - | - | 19,300 |
| Proceeds from share issuances, net of shares withheld for taxes | - | 16,700 | 21,500 | - |
| (payments) proceeds from share issuances, net of shares withheld for taxes | 500 | - | - | - |
| Repurchases of common stock | 247,800 | 0 | 24,200 | 148,100 |
| Shares surrendered for tax withholding | - | - | - | 5,200 |
| Contributions received from joint venture partner | - | - | - | 500 |
| Other net | -800 | -700 | -1,300 | - |
| Net cash flows (used in) provided by financing activities | -632,600 | 465,900 | -344,700 | -37,800 |
| Effect of exchange rate changes on cash and cash equivalents | 36,800 | -22,900 | 15,900 | -27,600 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | -53,000 | 104,600 | 104,100 | -425,200 |
| Statement table | 0 | - | - | - |
| Cash and cash equivalents and restricted cash at beginning of year | 638,900 | 534,300 | 430,200 | 855,400 |
| Cash and cash equivalents and restricted cash at end of year | 585,900 | 638,900 | 534,300 | 430,200 |
IDEX CORP DE (IEX)
IDEX CORP DE (IEX)